TELEFLEX INCORPORATED (TFX) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 87.50M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 2.72B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 6.79B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $87.50M | $2.72B | (m) | (m) | $6.79B | (m) |
| 2026-03-31 | (m) | (m) | (m) | $2.51B | (m) | (m) | $6.78B | (m) |
| 2025-12-31 | (m) | (m) | $100.00M | $2.54B | (m) | (m) | $6.95B | (m) |
| 2025-09-28 | (m) | (m) | $100.00M | $2.57B | (m) | (m) | $7.87B | (m) |
| 2025-06-29 | (m) | (m) | $100.00M | $1.80B | (m) | (m) | $7.38B | (m) |
| 2025-03-30 | (m) | (m) | $100.00M | $1.81B | (m) | (m) | $7.16B | (m) |
| 2024-12-31 | (m) | (m) | $100.00M | $1.56B | (m) | (m) | $7.10B | (m) |
| 2024-09-29 | (m) | (m) | (m) | $1.66B | (m) | (m) | $7.49B | (m) |
| 2024-06-30 | (m) | (m) | (m) | $1.62B | (m) | (m) | $7.44B | (m) |
| 2024-03-31 | (m) | (m) | (m) | $1.67B | (m) | (m) | $7.48B | (m) |
| 2023-12-31 | (m) | (m) | $87.50M | $1.73B | (m) | (m) | $7.53B | (m) |
| 2023-10-01 | (m) | (m) | $87.50M | $1.95B | (m) | (m) | $7.49B | (m) |
| 2023-07-02 | (m) | (m) | (m) | $1.47B | (m) | (m) | $6.90B | (m) |
| 2023-04-02 | (m) | (m) | (m) | $1.55B | (m) | (m) | $6.92B | (m) |
| 2022-12-31 | (m) | (m) | $87.50M | $1.62B | (m) | (m) | $6.93B | (m) |
| 2022-09-25 | (m) | (m) | (m) | $1.59B | (m) | (m) | $6.76B | (m) |
| 2022-06-26 | (m) | (m) | (m) | $1.61B | (m) | (m) | $6.73B | (m) |
| 2022-03-27 | (m) | (m) | (m) | $1.74B | (m) | (m) | $6.87B | (m) |
| 2021-12-31 | (m) | (m) | $110.00M | $1.74B | (m) | (m) | $6.87B | (m) |
| 2021-09-26 | (m) | (m) | $101.25M | $1.95B | (m) | (m) | $7.04B | (m) |
| 2021-06-27 | (m) | (m) | $92.50M | $2.22B | (m) | (m) | $7.07B | (m) |
| 2021-03-28 | (m) | (m) | (m) | $2.30B | (m) | (m) | $7.03B | (m) |
| 2020-12-31 | (m) | (m) | $100.50M | $2.38B | (m) | (m) | $7.15B | (m) |
| 2020-09-27 | (m) | (m) | $91.75M | $2.04B | (m) | (m) | $6.61B | (m) |
| 2020-06-28 | (m) | (m) | $83.00M | $2.33B | (m) | (m) | $6.77B | (m) |
| 2020-03-29 | (m) | (m) | $53.63M | $2.34B | (m) | (m) | $6.70B | (m) |
| 2019-12-31 | (m) | (m) | $50.00M | $1.86B | (m) | (m) | $6.31B | (m) |
| 2019-09-29 | (m) | (m) | $50.00M | $1.95B | (m) | (m) | $6.26B | (m) |
| 2019-06-30 | (m) | (m) | $50.00M | $2.08B | (m) | (m) | $6.31B | (m) |
| 2019-03-31 | (m) | (m) | (m) | $2.07B | (m) | (m) | $6.27B | (m) |
| 2018-12-31 | (m) | (m) | (m) | $2.07B | (m) | (m) | $6.28B | (m) |
| 2018-09-30 | (m) | (m) | (m) | $2.08B | (m) | (m) | $6.20B | (m) |
| 2018-07-01 | (m) | (m) | (m) | $2.15B | (m) | (m) | $6.18B | (m) |
| 2018-04-01 | (m) | (m) | (m) | $2.15B | (m) | (m) | $6.30B | (m) |
| 2017-12-31 | (m) | (m) | (m) | $2.16B | (m) | (m) | $6.18B | (m) |
| 2017-10-01 | (m) | (m) | $77.25M | $2.17B | (m) | (m) | $5.68B | (m) |
| 2017-07-02 | (m) | (m) | $112.04M | $1.89B | (m) | (m) | $5.29B | (m) |
| 2017-04-02 | (m) | (m) | $131.09M | $1.96B | (m) | (m) | $5.23B | (m) |
| 2016-12-31 | (m) | (m) | (m) | $850.25M | (m) | (m) | $3.89B | (m) |
| 2016-09-25 | (m) | (m) | $181.90M | $849.97M | (m) | (m) | $4.00B | (m) |
| 2016-06-26 | (m) | (m) | $173.95M | $907.93M | (m) | (m) | $4.00B | (m) |
| 2016-03-27 | (m) | (m) | $421.20M | $641.97M | (m) | (m) | $3.94B | (m) |
| 2015-12-31 | (m) | (m) | (m) | $646.00M | (m) | (m) | $3.88B | (m) |
| 2015-09-27 | (m) | (m) | $416.69M | $646.00M | (m) | (m) | $3.91B | (m) |
| 2015-06-28 | (m) | (m) | $415.99M | $696.00M | (m) | (m) | $3.98B | (m) |
| 2015-03-29 | (m) | (m) | $401.56M | $700.00M | (m) | (m) | $3.92B | (m) |
| 2014-12-31 | (m) | (m) | (m) | $700.00M | (m) | (m) | $3.98B | (m) |
| 2014-09-28 | (m) | (m) | $360.66M | $700.00M | (m) | (m) | $4.06B | (m) |
| 2014-06-29 | (m) | (m) | $357.57M | $700.00M | (m) | (m) | $4.06B | (m) |
| 2014-03-30 | (m) | (m) | $-354.56M | $930.00M | (m) | (m) | $4.24B | (m) |
| 2013-12-31 | (m) | (m) | $-351.59M | $930.00M | (m) | (m) | $4.21B | (m) |
| 2013-09-29 | (m) | (m) | (m) | $980.69M | (m) | (m) | $3.79B | (m) |
| 2013-06-30 | (m) | (m) | (m) | $970.83M | (m) | (m) | $3.72B | (m) |
| 2013-03-31 | (m) | (m) | (m) | $968.03M | (m) | (m) | $3.69B | (m) |
| 2012-12-31 | (m) | (m) | (m) | $965.28M | (m) | (m) | $3.74B | (m) |
| 2012-09-30 | (m) | (m) | (m) | $962.60M | (m) | (m) | $3.67B | (m) |
| 2012-07-01 | (m) | (m) | (m) | $959.95M | (m) | (m) | $3.61B | (m) |
| 2012-04-01 | (m) | (m) | (m) | $957.36M | (m) | (m) | $3.65B | (m) |
| 2011-12-31 | (m) | (m) | (m) | $954.81M | (m) | (m) | $3.92B | (m) |
| 2011-09-25 | (m) | (m) | (m) | $952.32M | (m) | (m) | $3.87B | (m) |
| 2011-06-26 | (m) | (m) | (m) | $949.87M | (m) | (m) | $3.88B | (m) |
| 2011-03-27 | (m) | (m) | (m) | $822.47M | (m) | (m) | $3.68B | (m) |
| 2010-12-31 | (m) | (m) | $72.50M | $813.41M | (m) | (m) | $3.64B | (m) |
| 2010-09-26 | (m) | (m) | (m) | $904.41M | (m) | (m) | $3.80B | (m) |
| 2010-06-27 | (m) | (m) | (m) | $1.13B | (m) | (m) | $3.74B | (m) |
| 2009-12-31 | (m) | (m) | (m) | $1.19B | (m) | (m) | $3.84B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |